Literature DB >> 2342729

Dilation and evacuation for second-trimester genetic pregnancy termination.

L P Shulman1, F W Ling, C M Meyers, D R Shanklin, J L Simpson, S Elias.   

Abstract

Dilation and evacuation (D&E) is the most common procedure for second-trimester pregnancy termination currently used by United States obstetrician-gynecologists. Although this method carries morbidity and mortality rates significantly lower than methods requiring labor induction, the procedure most commonly used for second-trimester genetic terminations seems to be labor induction (eg, vaginal prostaglandin suppositories). Many geneticists appear reluctant to recommend D&E over induction methods of pregnancy termination because they perceive that fetal abnormalities cannot be consistently confirmed by evaluation of the products of conception obtained by D&E. We report here 60 consecutive patients who underwent D&E (14-22 weeks' gestation) after detection of fetal abnormalities. The prenatal diagnoses were confirmed in all cases. Our experience thus indicates that D&E is reliable in confirming most prenatal diagnoses and should be the procedure of choice when second-trimester pregnancy termination is chosen because of fetal abnormalities.

Entities:  

Mesh:

Year:  1990        PMID: 2342729

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Induction of labor compared to dilation and evacuation for postmortem analysis.

Authors:  A K Lal; M A Kominiarek; N M Sprawka
Journal:  Prenat Diagn       Date:  2014-03-18       Impact factor: 3.050

Review 2.  Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion.

Authors:  Jessika A Ralph; Lee P Shulman
Journal:  Adv Ther       Date:  2019-04-19       Impact factor: 3.845

3.  Fetal diagnostic indications for second and third trimester outpatient pregnancy termination.

Authors:  Warren M Hern
Journal:  Prenat Diagn       Date:  2014-02-27       Impact factor: 3.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.